Quantifiable brain atrophy synthesis for benchmarking of cortical thickness estimation methods.

Cortical thickness (CTh) is routinely used to quantify grey matter atrophy as it is a significant biomarker in studying neurodegenerative and neurological conditions. Clinical studies commonly employ one of several available CTh estimation software tools to estimate CTh from brain MRI scans. In recent years, machine learning-based methods emerged as a faster alternative to the main-stream CTh estimation methods (e.g. FreeSurfer). Evaluation and comparison of CTh estimation methods often include various metrics and downstream tasks, but none fully covers the sensitivity to sub-voxel atrophy characteristic of neurodegeneration. In addition, current evaluation methods do not provide a framework for the intra-method region-wise evaluation of CTh estimation methods. Therefore, we propose a method for brain MRI synthesis capable of generating a range of sub-voxel atrophy levels (global and local) with quantifiable changes from the baseline scan. We further create a synthetic test set and evaluate four different CTh estimation methods: FreeSurfer (cross-sectional), FreeSurfer (longitudinal), DL+DiReCT and HerstonNet. DL+DiReCT showed superior sensitivity to sub-voxel atrophy over other methods in our testing framework. The obtained results indicate that our synthetic test set is suitable for benchmarking CTh estimation methods on both global and local scales as well as regional inter-and intra-method performance comparison.

Generative Model of Brain Microbleeds for MRI Detection of Vascular Marker of Neurodegenerative Diseases.

Cerebral microbleeds (CMB) are increasingly present with aging and can reveal vascular pathologies associated with neurodegeneration. Deep learning-based classifiers can detect and quantify CMB from MRI, such as susceptibility imaging, but are challenging to train because of the limited availability of ground truth and many confounding imaging features, such as vessels or infarcts. In this study, we present a novel generative adversarial network (GAN) that has been trained to generate three-dimensional lesions, conditioned by volume and location. This allows one to investigate CMB characteristics and create large training datasets for deep learning-based detectors. We demonstrate the benefit of this approach by achieving state-of-the-art CMB detection of real CMB using a convolutional neural network classifier trained on synthetic CMB. Moreover, we showed that our proposed 3D lesion GAN model can be applied on unseen dataset, with different MRI parameters and diseases, to generate synthetic lesions with high diversity and without needing laboriously marked ground truth.